Pneumococcal Serotype Shift
Executive Summary
Before any pneumococcal vaccine became available, there were roughly a dozen serotypes that caused about 70% to 80% of infections. As vaccines were introduced against these serotypes, other serotypes have taken their place.
You may also be interested in...
Genocea Aims To Take The T-Cell Century By The Horns
Although cancer grabs the spotlight for harnessing the immune system against tumors, other therapeutic areas and modalities are being developed in the shadows. Genocea Biosciences thinks it has a surefire way to identify novel antigens for T-cell vaccines. It hopes to shake up large infectious disease markets, and more.
US FDA And Sponsors Resolve Disclosure Issues On Complex Trial Design Pilot Projects
Agency officials can now discuss the ideas that have been accepted, though not in great detail.
US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.
Need a specific report? 1000+ reports available
Buy Reports